Inmed Pharmaceuticals INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Vivo Opportunity Fund Holdings and affiliates have disclosed a 21.7% beneficial ownership stake in InMed Pharmaceuticals following a merger announcement.